UPDATE 3/25/2020 – COVID-19: Keeping Up With A Moving Target

Join us in a follow up to last week’s webcast – COVID-19: Keeping Up with a Moving Target and the first of our new coronavirus educational activities as part of DKBmed’s Radio Hour. Today Dr. Auwaerter provides us with updates on infection rates, therapeutics, and testing. Plus, he answers your questions about topics such as proper protective equipment, use of ibuprofen with COVID-19, and pregnancy.

COVID-19 KEEPING UP WITH A MOVING TARGET

COVID-19 news is changing rapidly and we are all trying to stay on top of the latest medical information from trusted sources. Dr. Paul Auwaerter from Johns Hopkins School of Medicine covers what we know about the coronavirus outbreak in this podcast. Visit https://covid19.dkbmed.com/ for ongoing updates on COVID-19 from trusted medical professionals.

Increasing PrEP Uptake in PWID

Take our post-test to claim CME credits.

To read a companion newsletter click here.

People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health? In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medical Center takes us into the clinic to explain how current evidence-based strategies can increase the uptake of HIV pre-exposure prophylaxis in this vulnerable population.

HCV: Management Beyond the Liver

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The extrahepatic manifestations of chronic HCV can affect many different organ systems. In this eViralHepatitis Review podcast, Dr. Rajender Reddy from the University of Pennsylvania’s Perelman School of Medicine discusses clinical approaches to identifying and managing the effects of HCV infection beyond the liver.

COPD in Primary Care: Clinical Directions

Volume 1, Issue 8

In this issue:

Spirometry, FEV1, the FEV1/FVC ratio, the GOLD guidelines — in this case-based podcast, Dr. Emily Brigham from The Johns Hopkins University School of Medicine explains how these elements work together to provide primary care practitioners the information they need to diagnose, manage, and (when necessary) refer their patients with COPD to a pulmonary specialist.

Take our post-test to claim CME credits: https://elit.dkbmed.com/issues/50/test

Read the companion newsletter: https://elit.dkbmed.com/issues/49

Primary Care Practice Management: New Perspectives on COPD

Volume 1, Issue 6

In this issue:

In her recent Newsletter issue, Dr. Nirupama Putcha from The Johns Hopkins University School of Medicine analyzed the impact the newer research may have on improving outcomes in patients with COPD.

In this case-based podcast, she discusses how that information can be put to clinical use in primary care practice.

Take our post-test to claim CME credits: https://elit.dkbmed.com/issues/47/test

Read the companion newsletter: https://elit.dkbmed.com/issues/46

Two Drug ART? — Clinical Considerations

In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Practice Insights: Managing T2DM in Older Adults

Volume 1, Issue 4

In this issue:

Avoiding hypoglycemia, recognizing cognitive dysfunction, and individualizing treatment to account for renal insufficiency, cardiovascular disease and other comorbidities — these are just some of the factors that impact treatment decision-making for older adults with type 2 diabetes.

In this issue, Dr. Amisha Wallia (Feinberg School of Medicine) and Dr. Susan Karam (Ochsner Medical Center) take us to the exam room to translate the information from their recent Newsletter Issue into real-world clinical practice.

Take our post-test to claim CME credits.

To read a companion newsletter click here

Continuous Alternating Therapies: A Clinical Perspective

Volume 8, Issue 11.

In this issue:

Inhaled antibiotics have become the foundation of treating chronic respiratory tract Pseudomonas infection in individuals with cystic fibrosis. But what happens when inhaled monotherapy doesn’t sufficiently manage the symptoms? Which patients are appropriate candidates for treatment with multiple inhaled agents?  Which medications are appropriate for continuous alternating therapy (CAT)?

In this Issue, Dr. Elliott Dasenbrook from the Cleveland Clinic brings the evidence he analyzed in his recent eCysticFibrosis Review Newsletter issue (Vol 8; Issue 10) into the clinic to help guide clinical decision-making.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

“U=U” — Clinical Considerations

Volume 4, Issue 12

“U=U” — an Undetectable HIV viral load means Untransmittable HIV virus.  In her recent eHIV Newsletter Issue (Vol. 4; No. 11), Dr. Jill Blumenthal from the Division of Infectious Diseases and Global Public Health at the University of California San Diego analyzed the current evidence strongly supporting this concept.  In this Podcast, she discusses “U=U” from the clinical perspective, and models how it can help promote patient safety.

Take our post-test to claim CME credits.

To read a companion newsletter click here